###### Strengths and limitations of this study

-   The study protocol is informed by the Cochrane Collaboration systematic review methods and adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols.

-   Of the studies identified for inclusion, the full publication will be independently assessed for quality by two authors.

-   The concept of an organisational intervention is not definitive and will likely require discussion among the research team to establish which interventions are included/excluded in the review.

-   Only papers where caesarean section is the primary outcome measure will be included, hence potentially relevant studies may be omitted if caesarean section is a secondary outcome.

-   Inadequate reporting of complex interventions used in individual studies may limit the usability of the review findings.

Introduction {#s1}
============

Based on systematic review evidence, the WHO recently concluded that caesarean section rates of greater than 10% are not linked to lower maternal and neonatal mortality rates.[@R1] In 2014, the rates of childbirth by caesarean section across 150 countries ranged from 6% to 27.2% (average 18.6%).[@R3] In high-income countries, the use of caesarean sections has increased steadily over the last decade.[@R3] The reasons for the increase are varied and complex and are reported to include malpractice liability, an increase in acuity of women birthing, scheduling convenience and an increase in the number of women with pre-existing medical complications, such as diabetes, when they become pregnant.[@R3] Professional associations in nations such as Canada,[@R6] Australia and New Zealand[@R7] and the USA[@R8] have issued guidelines to promote vaginal birth for uncomplicated pregnancies, whenever possible. It is also acknowledged in the guidelines that, based on individual assessment and need, planned caesarean sections should be recommended in selected cases, for example, if women have experienced previous (physical or psychological) trauma.[@R9]

While caesarean section expedites birth in obstetric emergencies, the role of planned surgical birth in reducing or minimising potential for subsequent morbidity, for example, providing perineal protection for a woman with previous severe perineal trauma, is as yet unknown.[@R10] Planned and unplanned caesarean births are associated with adverse maternal and neonatal outcomes. Caesarean births increase the risk of maternal mortality compared with vaginal birth and significantly increase the risk of death through complications of anaesthesia, wound and genital tract infection and thromboembolism.[@R11] Postoperative surgical wound infections have been reported to develop in around 5% of women while still hospital inpatients.[@R12] Genital tract sepsis was one of the leading causes of direct maternal death in women giving birth in the UK during 2009--2013,[@R13] with most deaths occurring following discharge from hospital and all forms of operative birth associated with increased risk of sepsis. Planned caesarean section is associated with a higher risk of hysterectomy, anaesthetic complications and obstetric shock compared with planned vaginal birth.[@R14] Increases in maternal morbidity occur with subsequent caesarean sections, including increased risks of placenta acreta, cystotomy, bowel injury, ureteral injury, ileus, postpartum ventilation, intensive care admission, haemorrhage, hysterectomy and blood transfusion.[@R15] Other adverse maternal risks associated with caesarean sections are endometritis, thrombosis and bladder or ureter damage requiring further surgery.[@R16] There are also worse health outcomes for women in subsequent pregnancies[@R17]; for example, the risk of peripartum hysterectomy increases if a woman has had a previous caesarean birth.[@R18]

Newborns delivered via caesarean section tend to have higher Apgar scores than those delivered vaginally, but require more oxygen resuscitation and have higher risk of onset of physiological jaundice compared with babies born vaginally.[@R19] The duration of inpatient stay has traditionally been longer for women following caesarean section births compared with normal or operative vaginal births. For example, in Victoria, Australia, the 2009--2010 length of stay following caesarean section was 4.51 days compared with an inpatient duration of 1.93 days following vaginal birth.[@R20] However, inpatient duration has been declining following caesarean births with anecdotal evidence that women in the UK are being discharged home within 48 hours of a planned caesarean birth following the introduction of enhanced recovery after surgery pathways for major elective surgery.[@R21] The impact of early postnatal discharge following caesarean birth on women's health and other postnatal care outcomes in community settings has yet to be established.

With respect to neonatal outcomes, compared with planned vaginal births, babies born by elective caesarean section experience more admissions to neonatal units, greater risk of respiratory morbidity and higher mortality rates.[@R22] Lower rates of breastfeeding initiation have been reported following caesarean birth as a consequence of a lack of effective pain relief impacting on a woman's ability to care for her baby,[@R23] or due to separation of the mother and baby following birth. Surgery may impact on postpartum prolactin levels resulting in a subsequent delay in the onset of lactation,[@R24] which maternity staff may fail to address or take into account when planning care for women postoperatively. Furthermore, evidence suggests that caesarean section surgery is more costly than vaginal delivery in low-risk populations.[@R26]

Urgent calls have been made by organisations, for example, the US Office of Disease Prevention and Health Promotion[@R27] and the WHO,[@R28] to reduce the rates of unnecessary caesarean sections. Extrapolating from the complications associated with caesarean section, predicted outcomes from a reduction in caesarean section rates include: improved safety through reduced incidents and admissions of babies to neonatal care; reduced perinatal and maternal morbidity and mortality; higher rates of breastfeeding (particularly in the long term); improved quality of maternity care; significant cost savings and improved national compliance with WHO recommendations.

The study described in this protocol broadly seeks to establish evidence for the effectiveness of maternity service organisational interventions developed to reduce planned and unplanned caesarean births. The Cochrane Effective Practice and Organisation of Care group defines organisational interventions as '...those which involve a change in the structure or delivery of healthcare. In other words, an organisational intervention is a change in who delivers healthcare, how care is organised, or where care is delivered'.[@R29]

Methods and analysis {#s2}
====================

Aim {#s2a}
---

Our specific aim is to systematically review published evidence on maternity service organisational interventions that aim to reduce planned and unplanned caesarean section rates.

Design {#s2b}
------

This systematic review protocol is informed by the Cochrane Collaboration systematic review methods and adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P).[@R30]

The following criteria will be used to screen studies, based on the 'PICO' (participants, intervention, comparator and outcome) approach:

### Inclusion criteria {#s2b1}

Studies will be included only if they are published in peer-reviewed journals and report on organisational interventions and planned and unplanned caesarean section rates. Other inclusion criteria consist of:Study designs: randomised controlled trials (RCTs), cluster-randomised controlled trials, quasi-randomised controlled trials, controlled before and after studies and interrupted time series studies.Types of setting and participants: obstetric-led maternity services able to provide support for women undergoing planned or unplanned CS birth. Maternity care clinicians, including midwives, obstetricians, nurses, paediatricians, family doctors and anaesthetists, maternity care managers and maternity care educators.Types of interventions and comparators: These may take the form of maternity service organisational interventions, for example, feedback mechanisms, incentives, education, reminder mechanism and models of care. The strategy may comprise a single component (eg, education only) or be multifaceted (comprising two or more components, eg, education and reminders) aimed to reduce caesarean section rates versus usual care (no such organisational intervention). Some interventions, typically those that are multifaceted, comprising interacting components, are described as complex interventions.[@R31]Types of outcome measures: Studies that report objectively measured or self-reported (using validated instruments) outcomes. Planned, unplanned and overall caesarean section rates are expected to be the primary outcome measure. Secondary outcome measures include admissions to neonatal intensive care units or special care units, maternal adverse events (eg, postpartum haemorrhage, wound infection and thromboembolism), breastfeeding initiation and duration, maternal and newborn duration of inpatient stay, women's experiences of care, adherence to best practice guidelines by health professionals, health professionals' satisfaction, confidence, competence, attitudes, knowledge and self-efficacy.

We will not apply search restrictions according to language or the income level of countries. Based on title and abstract, potentially relevant publications in other languages will be translated into English by accredited professional translators.

### Exclusion criteria {#s2b2}

Exclusions will be made based on types of interventions. For the purposes of this study, medical interventions (eg, drugs to induce labour, episiotomy and instrumental delivery), lifestyle interventions (eg, nutrition and physical activity programmes for expectant mothers) and labour interventions (eg, water births, epidural analgesia, augmentation of labour) are not defined as organisational interventions and, hence, will be excluded.

Setting {#s2c}
-------

The organisations relevant to this study include hospitals, maternity care clinics and health centres (described as maternity services). Organisational interventions could include, for example, staff training, service-wide policies or new models or methods of organising maternity care and decision support tools for women and clinicians.

Search strategy {#s2d}
---------------

The systematic search of the literature will involve three stages:

### Database search {#s2d1}

Studies published from 1 January 1980 to 31 December 2017 will be identified using the following databases:The Cochrane Central Register of Controlled TrialsCumulative Index to Nursing and Allied Health LiteratureMEDLINEMaternity and Infant CareEMBASESCOPUS

Search terms will be developed from our knowledge of existing literature and advice of qualified health librarians, and will include controlled vocabulary and keyword terms related to: (1) caesarean (cesarean, caesarian, cesarian) section AND (2) organis(z)ational interventions AND (3) quality outcomes AND (4) research design. The search terms will be applied according to the nuances of each database; as an example, see the planned MEDLINE search in [box 1](#B1){ref-type="boxed-text"}. The platforms for each database are outlined in [table 1](#T1){ref-type="table"}.Box 1Search terms used in MEDLINECesarean Section/((caesarean or cesarean) adj (section? or birth? or deliver\$)).ti,ab.(c-section? or c section).ti,ab.((Peri natal or peri-natal) adj care).ti,ab.or/1--4\*health maintenance organizations/exp Organizational Innovation/exp Health Services/Health Facilities/9exp Hospitals/exp Hospital Restructuring/exp Health Planning/Health Policy/Clinical Governance/exp Maternal Health Services/exp 'Organization and Administration'/Program Development/Capacity Building/exp 'Delivery of Health Care'/'Attitude of Health Personnel'/exp 'Quality of Health Care'/exp 'Risk Management'/adverse event.ti,ab.exp Patient Care Team/interdisciplinary.ti,ab.exp 'Interprofessional Relations'/exp 'Quality Assurance, Health Care'/exp Motivation/exp safety/or patient safety/organizational culture/((program\* or facilit\*) adj1 (health or care or intervention\*)).ti,ab.capacity building.ti,ab.(organi\* adj2 (learning or change or changing or management or restructure or redesign or develop\*)).ti,ab.((quality or safety or change) adj2 (program or improve\*)).ti,ab.or/6--35and/5,36exp Morbidity/exp Mortality/exp risk/ae.fs.co.fs.audit\*.ti,ab.or/38--4337 and 44randomized controlled trial.pt.controlled clinical trial.pt.randomized.ab.placebo.ab.drug therapy.fs.randomly.ab.trial.ab.groups.ab.or/46--53exp animals/not humans.sh.54 not 55and/45,56limit 57 to yr='1980-Current'

###### 

Platforms for each database

  Database                                                                                Platform
  --------------------------------------------------------------------------------------- ---------------------------------------------------
  The Cochrane Central Register of Controlled Trials                                      The Cochrane Library through Wiley Online Library
  Cumulative Index to Nursing and Allied Health Literature (CINAHL) (excluding MEDLINE)   EBSCO
  MEDLINE                                                                                 Ovid
  Maternity and Infant Care                                                               Ovid
  EMBASE (excluding MEDLINE)                                                              EMBASE
  SCOPUS                                                                                  Sciverse

### Systematic literature reviews {#s2d2}

Published systematic literature reviews, captured in our database search and identified as relevant to our review objective, will be used to cross-check included studies and identify additional eligible references.

### Reviewing reference lists {#s2d3}

The reference lists of included studies will be reviewed to identify additional eligible references.

Screening {#s2e}
---------

EndNote X7 will be used to manage the results of all searches and to facilitate the screening process. A unique identifier will be automatically assigned by EndNote X7 to every publication retrieved in the three-stage search process to enable tracking of articles. Following deduplication, two authors will independently screen the titles and abstracts of all publications retrieved and an inter-rater calculation will be performed to reveal the level of agreement. A Microsoft Excel spreadsheet will be used to track the screening process.

Of the studies identified for inclusion, the full publications will be retrieved and reviewed by two authors. Following review of the full text, the inclusion/exclusion status and rationale will be recorded for each study. All disagreements regarding inclusion/exclusion will be resolved through consensus. The PRISMA[@R30] flow diagram will be used for reporting the screening process.

Data extraction {#s2f}
---------------

A purpose-designed Microsoft Excel spreadsheet will be used for recording extracted data. One author will independently extract data from each included publication. Extracted data will include: year, authors, publication title, research question or study purpose, study design, context, subjects/participants, sample size, theoretical/conceptual framework, intervention (type, elements), definition of concepts, data collection methods, instrumentation, reliability coefficients, validity measures and relevant results (the relationship between caesarean section rates and organisational interventions). Extracted data will be checked for accuracy and completeness by a second author and any discrepancies resolved by consensus.

Methodological quality assessments {#s2g}
----------------------------------

Each included publication will be independently assessed for quality by two authors. The risk of bias tool recommended by the Cochrane Collaboration and described in the Cochrane Handbook for Systematic Reviews of Interventions[@R32] will be used for RCTs. This tool addresses six domains: sequence generation; allocation concealment; blinding of participants, personnel and outcome assessors; incomplete outcome data; selective outcome reporting; and other potential threats to validity.[@R32] Each domain will be graded as either 'low risk', 'high risk' or 'unclear risk' for bias.

The Quality Assessment Tool for Quantitative Studies[@R33] will be used for all other research designs. This tool addresses eight domains: selection bias, study design, confounders, blinding, data collection, participant withdrawals, intervention integrity and analysis. The quality assessment across the eight domains allows an overall quality rating to be achieved: 'strong', 'moderate' or 'weak'. This tool has been evaluated for construct and content validity and was found to have excellent inter-rater agreement for the overall quality rating.[@R34]

Discrepancies in author ratings using either tool will be identified, discussed and resolved by consensus. Risk of bias and quality rating will be considered in the analysis of data (sensitivity analysis), but will not determine a study's inclusion or exclusion. For evidence of potential reporting biases, funnel plots will be used.

Data analysis and synthesis {#s2h}
---------------------------

### Measures of treatment effect {#s2h1}

Where studies report dichotomous outcomes, we will report results as a summary risk ratio with 95% CI. For studies reporting continuous outcomes, we will report the mean difference if outcomes are measured in the same way between studies. We will use the standardised mean difference to combine trials that measure the same outcome, but use different methods.

For controlled before and after studies, we will report relative effects. For dichotomous outcomes, we will report the risk ratio adjusting for baseline differences in the outcome measures. For continuous variables, we will report on the relative change, adjusting for baseline differences in the outcome measures.

For interrupted time series studies, the changes in intercept and slope coefficients will be compared between the postintervention and preintervention periods via segmented regression technique, controlling for the overall rate of outcome trend. Mean changes will be used to combine studies measuring the same outcomes.

### Cluster-randomised trials {#s2h2}

We will combine results from cluster-randomised trials with individually randomised trials if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. We will adjust their SE using the reported intracluster correlation coefficient. We will also acknowledge heterogeneity in the unit of randomisation and perform a sensitivity analysis to investigate the effects of the randomisation unit.

### Subgroup analysis {#s2h3}

Subgroup analyses, based on the Robson caesarean section classification system, will be undertaken to assess the effectiveness of interventions by participant type. The 10-Group Classification System was developed to enable analysis of events and outcomes associated with labour and delivery according to different types of clinical intervention.[@R35]

### Dealing with missing data {#s2h4}

For included studies, we will note levels of attrition. A sensitivity analysis will be undertaken to assess the impact of including studies with high levels of missing data in the overall assessment of treatment effect. For all outcomes, we will carry out analyses, as far as possible, on an intention-to-treat basis. The denominator for each outcome in each trial will be the number randomised minus any participants whose outcomes are known to be missing.

### Assessment of heterogeneity {#s2h5}

We will assess statistical heterogeneity in each meta-analysis using the τ², I² and χ² statistics. We will regard heterogeneity as substantial if an I² is greater than 30%, and either the τ² is greater than zero or there is a low P value (less than 0.10) in the χ² test for heterogeneity.

### Data synthesis {#s2h6}

We will conduct statistical analysis using the Review Manager software.[@R36] A fixed-effect meta-analysis with 95% CI will be used for combining data where it is reasonable to assume that studies are estimating the same intervention, and the study populations and methods are assessed to be similar. If significant heterogeneity is detected, we will use random-effects meta-analysis to produce an overall summary. If we use random-effects analyses, the results will be presented as the average treatment effect with 95% CI, and the estimates of τ² and I².

In the event that studies have significant clinical heterogeneity, we will present narrative, descriptive and qualitative reporting of the data. Because of the complex nature of, and variation in, organisational interventions, there may be inadequate numbers of studies that are similar enough to enable combination of the results statistically. The approach for the narrative reporting will be informed by guidelines described by Grimshaw.[@R37] This will include: first, grouping studies into categories based on the style of the organisational intervention, research design and setting; then, conducting within study analysis to describe the findings and characteristics, quality of the study and design; and finally, cross-study synthesis to aggregate all included studies, compare the effectiveness of different interventions and discuss the relationships in the findings.

### Sensitivity analysis {#s2h7}

We will perform sensitivity analysis based on the risk of bias in the randomisation, allocation concealment, blinding and loss to follow-up of the studies.

### Protocol amendments {#s2h8}

Any amendments to the protocol will be documented on the International Prospective Register of Systematic Reviews (PROSPERO) and in the final manuscript.

### Patient and public involvement {#s2h9}

Patients and the public were not involved in the development of this protocol and they will not participate in the conduct of the systematic review.

Discussion {#s3}
==========

This paper outlines a protocol for the systematic review search strategy, extraction method, synthesis and appraisal of the quality of published evidence in relation to maternity service organisational interventions that aim to reduce planned and unplanned caesarean section rates. The results of this study will provide a framework to assist decision makers in maternity service settings regarding the anticipated outcomes of, and most effective approaches for, reducing caesarean rates. The results will address a gap in the literature and help to answer calls for reduced caesarean section rates globally.

As described in this protocol, the Cochrane Collaboration's guide for systematic reviews of the literature is used to inform the research design, with three main adaptions. First, screening of studies included in previously published systematic reviews that addressed a similar but not identical question, will be undertaken. This will improve the rigour of our search strategy and enable a cross-check of our database search yield. Second, it is typical to use strict criteria when screening studies. In our protocol, we have added detail at every level of the inclusion criteria (design, participants, intervention type and outcome measures) and exclusion criteria (describing excluded interventions) to expedite the screening process and provide clear criteria for reviewers. Finally, two quality assessment tools will be used in our research. Although risk of bias tools are appropriate for RCTs, because we anticipate including other research designs, a second quality assessment tool is included to enable assessment of other study designs.

This protocol has potential study design limitations. The definition of an organisational intervention is not definitive and, hence, we anticipate that including/excluding on these criteria will involve robust discussion between reviewers to achieve a consensus position. Relevant examples of organisational interventions for this setting will be revealed with potential application for future research and practice. The screening tool stipulates that we will also exclude papers where caesarean sections are not the primary outcome measure. Hence, interventions where caesarean sections are a secondary outcome will not be included and this may exclude potentially relevant studies. Risk of bias assessments have been found to be difficult to implement in terms of two domains: incomplete outcome data and selective reporting of outcomes,[@R38] and this may limit the validity of assessments performed. To reduce the likelihood of these domains impacting our assessments, two authors will perform risk of bias assessments for all included studies, discuss discrepancies in decisions and draw on the Cochrane Collaboration's supporting material as required. In the event that consensus is not reached, a third author will be consulted for a final decision. Finally, inconsistent and insufficient detail in the reports of individual studies of complex interventions may limit the usefulness of the review findings.

In conclusion, the reported outcomes of maternity service organisational interventions that aim to reduce caesarean section rates will be synthesised and statistically (if possible) and narratively compared. The results will be useful in informing decisions about optimal organisational approaches to reduce the rates of caesarean sections in maternity settings. Predicted benefits arising from a reduction in rates include improved maternal and infant care and cost-savings for resource-stretched healthcare providers
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